Novartis' Zolgensma Had Manipulated Data In Application, US FDA Says

 
• By Derrick Gingery
  
FDA entrance sign 2016
US FDA said it was told of the manipulated data after Zolgensma's approval, but that AveXis knew before clearance. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies